These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


277 related items for PubMed ID: 11053616

  • 1. Human anti-heparin-platelet factor 4 antibodies are capable of activating primate platelets: towards the development of a HIT model in primates.
    Ahmad S, Jeske WP, Walenga JM, Aldabbagh A, Iqbal O, Fareed J.
    Thromb Res; 2000 Oct 01; 100(1):47-54. PubMed ID: 11053616
    [Abstract] [Full Text] [Related]

  • 2. Development of a non-human primate sub-clinical model of heparin-induced thrombocytopenia: platelet responses to human anti-heparin-platelet factor 4 antibodies.
    Untch B, Ahmad S, Messmore HL, Schultz CL, Ma Q, Hoppensteadt DA, Walenga JM, Fareed J.
    Thromb Res; 2002 Apr 15; 106(2):149-56. PubMed ID: 12182915
    [Abstract] [Full Text] [Related]

  • 3. Physiological changes in membrane-expressed platelet factor 4: implications in heparin-induced thrombocytopenia.
    Prechel MM, Jeske WP, Walenga JM.
    Thromb Res; 2010 Apr 15; 125(4):e143-8. PubMed ID: 19931120
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Prevalence, isotype, and functionality of antiheparin-platelet factor 4 antibodies in patients treated with heparin and clinically suspected for heparin-induced thrombocytopenia. The pathogenic role of IgG.
    Untch B, Ahmad S, Jeske WP, Messmore HL, Hoppensteadt DA, Walenga JM, Lietz H, Fareed J.
    Thromb Res; 2002 Jan 15; 105(2):117-23. PubMed ID: 11958801
    [Abstract] [Full Text] [Related]

  • 6. Distinguishing between anti-platelet factor 4/heparin antibodies that can and cannot cause heparin-induced thrombocytopenia.
    Nazi I, Arnold DM, Warkentin TE, Smith JW, Staibano P, Kelton JG.
    J Thromb Haemost; 2015 Oct 15; 13(10):1900-7. PubMed ID: 26291604
    [Abstract] [Full Text] [Related]

  • 7. Beneficial effect of exogenous platelet factor 4 for detecting pathogenic heparin-induced thrombocytopenia antibodies.
    Vayne C, Guery EA, Kizlik-Masson C, Rollin J, Bauters A, Gruel Y, Pouplard C.
    Br J Haematol; 2017 Dec 15; 179(5):811-819. PubMed ID: 29048130
    [Abstract] [Full Text] [Related]

  • 8. Serotonin-release assay-positive but platelet factor 4-dependent enzyme-immunoassay negative: HIT or not HIT?
    Warkentin TE, Smythe MA, Ali MA, Aslam N, Sheppard JI, Smith JW, Moore JC, Arnold DM, Nazy I.
    Am J Hematol; 2021 Mar 01; 96(3):320-329. PubMed ID: 33326124
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Activation of platelets by sera containing IgG1 heparin-dependent antibodies: an explanation for the predominance of the Fc gammaRIIa "low responder" (his131) gene in patients with heparin-induced thrombocytopenia.
    Denomme GA, Warkentin TE, Horsewood P, Sheppard JA, Warner MN, Kelton JG.
    J Lab Clin Med; 1997 Sep 01; 130(3):278-84. PubMed ID: 9341987
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Platelet-Activating Antibodies Are Detectable at the Earliest Onset of Heparin-Induced Thrombocytopenia, With Implications for the Operating Characteristics of the Serotonin-Release Assay.
    Warkentin TE, Arnold DM, Kelton JG, Sheppard JI, Smith JW, Nazy I.
    Chest; 2018 Jun 01; 153(6):1396-1404. PubMed ID: 29325985
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. 5B9, a monoclonal antiplatelet factor 4/heparin IgG with a human Fc fragment that mimics heparin-induced thrombocytopenia antibodies.
    Kizlik-Masson C, Vayne C, McKenzie SE, Poupon A, Zhou Y, Champier G, Pouplard C, Gruel Y, Rollin J.
    J Thromb Haemost; 2017 Oct 01; 15(10):2065-2075. PubMed ID: 28771917
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Activation of platelets by heparin-induced thrombocytopenia antibodies in the serotonin release assay is not dependent on the presence of heparin.
    Prechel MM, McDonald MK, Jeske WP, Messmore HL, Walenga JM.
    J Thromb Haemost; 2005 Oct 01; 3(10):2168-75. PubMed ID: 16150048
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Heparin-induced thrombocytopenia: a prospective study on the incidence, platelet-activating capacity and clinical significance of antiplatelet factor 4/heparin antibodies of the IgG, IgM, and IgA classes.
    Greinacher A, Juhl D, Strobel U, Wessel A, Lubenow N, Selleng K, Eichler P, Warkentin TE.
    J Thromb Haemost; 2007 Aug 01; 5(8):1666-73. PubMed ID: 17488345
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.